James Evans
- Molecular Biology
- Biomaterials top 5%
- Biomedical Engineering
- Surgery
- Pulmonary and Respiratory Medicine
- Co-authors
- Christine AllenCaitríona M. O’DriscollMeenakshi MalhotraRaphael DarcyE. Maurice BackettJohn F. CryanJianfeng GuoPauric Bannigan
- Topics
- RNA Interference and Gene Delivery (11 papers)Nanoparticle-Based Drug Delivery (9 papers)Childhood Cancer Survivors' Quality of Life (8 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
James Evans
77 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 142
- Molecular Biology 467
- Biomaterials 340
- Biomedical Engineering 241
- Surgery 189
- Pulmonary and Respiratory Medicine 175
Countries citing papers authored by James Evans
This map shows the geographic impact of James Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Evans more than expected).
Fields of papers citing papers by James Evans
This network shows the impact of papers produced by James Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Evans. The network helps show where James Evans may publish in the future.
Co-authorship network of co-authors of James Evans
This figure shows the co-authorship network connecting the top 25 collaborators of James Evans. A scholar is included among the top collaborators of James Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Evans. James Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | 8 | |
| 5 | 3 | |
| 6 | 9 | |
| 7 | 6 | |
| 8 | 11 | |
| 9 | 31 | |
| 10 | 1 | |
| 11 | 47 | |
| 12 | 68 | |
| 13 | 28 | |
| 14 | 13 | |
| 15 | 34 | |
| 16 | 17 | |
| 17 | Final clinical, pharmacokinetic and pharmacodynamic results of the phase I study of the novel poly(ADP-ribose)polymerase (PARP) inhibitor, AG014699, in combination with temozolomide | 6 |
| 18 | 62 | |
| 19 | 13 | |
| 20 | 15 |
About James Evans
James Evans is a scholar working on Theoretical Computer Science, Nutrition and Dietetics and Biomaterials, having authored 81 papers that have together received 1.5k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (11 papers), Nanoparticle-Based Drug Delivery (9 papers) and Childhood Cancer Survivors' Quality of Life (8 papers). The work is most often cited by research in Biomaterials (340 citations), Pharmaceutical Science (134 citations) and Molecular Biology (467 citations). James Evans has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Christine Allen, Caitríona M. O’Driscoll, Meenakshi Malhotra, Raphael Darcy, E. Maurice Backett, John F. Cryan, Jianfeng Guo, Pauric Bannigan, J. A. Heady and John Curtis. Their work appears in journals such as Journal of Clinical Oncology, Gastroenterology and Analytical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.